 |
 |
October
22, 2003 |
 |
|
 |
Volume
VI, Issue 105 |
 |
|
Email : info@otcjournal.com
URL : http://www.otcjournal.com
To
OTC Journal Members:
 |
ActionView (OTC
BB: AVWI) Delivers More Action |
|
ActionView, the subject of
a Trading Alert on October
16th, was out with another new contract after the market closed today.
The company announced it just completed the installation of six new scrolling
signs in the Sharpstown Shopping Mall in Houston, Texas.
Coming on the heels of last week's
announcement of an agreement to install 15 new signs in the $300 million
Dubai World Trade Center, it appears as if the company is gaining momentum.
ActionView's business model
provides significant recurring revenue streams for each of the installed
signs. The hard costs of manufacture and installation are absorbed after
the first five months. From that point forward, each sign is capable of
generating about $1,000 monthly in positive cash flow from advertising
revenues.
If the company can achieve its stated
goal of having 1,000 plus signs installed by September of next year, the
company will spin off about $1 million per month in excess cash flow before
corporate expenses. If they execute, the stock should be far north of the
current $1 level.
ActionView is closing in on
the 100 mark for number of signs installed. In order to reach the $2 price
target over the next six months, the company will probably need to deliver
a major order with a chain. Here's a partial list of company's considering
the ActionView signs for their stores:
-
Shoppers Drug Mart (825 locations)
-
Cineplex Odeon (135 locations)
-
Canadian Tire (636 locations)
-
Woolworth's of Australia (500 locations)
-
Vons Supermarkets (325 stores in
California)
-
Home Depot (1000 plus stores)
If the company delivers a deal with
any of these, I believe the $2 price target could become reality.
In the interim, these smaller orders should help the stock continue to
trade above its uptrend line, suggesting higher levels could be in the
cards. If you have a short term trading bias, maintain your $.75 per share
stop loss. The stock is digesting the gains it has made since the end of
August, but could begin another climb out soon, particularly if they continue
to deliver orders.
Charts Provided Courtesy
Of TradePortal.com |
|
| The OTCjournal.com Newsletter is
an independent electronic publication committed to providing our readers
with factual information on selected publicly traded companies. All
companies are chosen on the basis of certain financial analysis and other
pertinent criteria with a view toward maximizing the upside potential
for investors while minimizing the downside risk, whenever possible.
Moreover, as detailed below, this publication accepts compensation from
certain of the companies which it features. Likewise, this newsletter
is owned by MarketByte, LLC. To the degrees enumerated herein,
this newsletter should not be regarded as an independent publication.
Click
Here to view our compensation on every company we have ever covered,
or visit the following web address: http://www.otcjournal.com/disclaimer.html
for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html
for Trading Alerts. MarketByte LLC has been paid a fee of $30,000 and 125,000
free trading shares by a third party for coverage of ActionView. Please
review our policy on selling shares found in our Mission Statement on our
home page.
All statements and expressions are
the sole opinions of the editors and are subject to change without
notice. A profile, description, or other mention of a company in the newsletter
is neither an offer nor solicitation to buy or sell any securities
mentioned. While we believe all sources of information to be factual and
reliable, in no way do we represent or guarantee the accuracy thereof,
nor the statements made herein.
The editor, members of the editor's
family, and/or entities with which they are affiliated, are forbidden by
company policy to own, buy, sell or otherwise trade stock for their own
benefit in the companies who appear in the publication unless specifically
disclosed in the newsletter.
The profiles, critiques, and other
editorial content of the OTCjournal.com may contain forward-looking statements
relating to the expected capabilities of the companies mentioned herein.
THE READER SHOULD VERIFY ALL CLAIMS
AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED.
INVESTING IN SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE
OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT
LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY
WITHOUT THE EXPRESSED, WRITTEN CONSENT OF THE EDITORS OF OTCjournal.com.
We encourage our readers to invest
carefully and read the investor information available at the web sites
of the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or
the National Association of Securities Dealers ("NASD") at http://www.nasd.com.
We also strongly recommend that you read the SEC advisory to investors
concerning Internet Stock Fraud, which can be found at http://www.sec.gov/consumer/cyberfr.htm.
Disclaimer ID:$subst('Recip.userid') Readers can review all public filings
by companies at the SEC's EDGAR page. The NASD has published information
on how to invest carefully at its web site.
You
can unsubscribe from this list at any time by
Clicking
Here and HITTING SEND. If you are having difficulty removing
yourself or wish to change your address please go to http://listserv.otcjournal.com/opt.cgi?. |
|
|
|
Click Here to View the OTC Journal Disclosure
|
|
To subscribe to our newsletter, please enter your email address below.
Quotes are delayed 20 minutes.

|